1980
DOI: 10.1136/bmj.281.6235.275-a
|View full text |Cite
|
Sign up to set email alerts
|

Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.

Abstract: BRITISH MEDICAL JOURNAL 26 JULY 1980 275 properties at high blood concentrations. MacLeod and Lamberts3 have shown the dopamine agonist effects of high concentrations of haloperidol and pimozide on prolactin release. Seeman4 has shown that very high concentrations of some antipsychotic drugs may enhance presynaptic release of neurotransmitters, including dopamine. Altematively, at high concentrations of antipsychotic drugs maximal dopaminergic blockade may occur. Additional dosage increments would not prod… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

1983
1983
2010
2010

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 3 publications
0
7
0
Order By: Relevance
“…toms, [33][34][35] but oral bioavailability is variable, 36,37 and there is concern about its long-term use. Octreotide is also very effective, even when other agents fail, in part because of its ability to constrict the splanchnic circulation, 38 where most of the orthostatic blood pooling occurs.…”
Section: Shibao Et Al Hypertension In Autonomic Failure 473mentioning
confidence: 99%
“…toms, [33][34][35] but oral bioavailability is variable, 36,37 and there is concern about its long-term use. Octreotide is also very effective, even when other agents fail, in part because of its ability to constrict the splanchnic circulation, 38 where most of the orthostatic blood pooling occurs.…”
Section: Shibao Et Al Hypertension In Autonomic Failure 473mentioning
confidence: 99%
“…It is probably a partial α‐agonist but is a more potent venous than arterial constrictor. The efficacy and dose regimen for DHE is highly variable as a result of low oral bioavailability 21 . Doses range from 2.5–15 mg orally three times daily.…”
Section: Treatment Of Vvsmentioning
confidence: 99%
“…The efficacy and dose regimen for DHE is highly variable as a result of low oral bioavailability. 21 Doses range from 2.5-15 mg orally three times daily. Absorption is dependent on gut blood flow and therefore it should be taken with food.…”
Section: Dialysis-related Hypotension and Orthostatic Hypotensionmentioning
confidence: 99%
“…However, the results of chronic oral treatment with the drug have been equivocal,8' 9 perhaps because of low bioavailability.9' 10 Hemodynamic studies indicate that the blood pressure-enhancing effect of dihydroergotamine in orthostatic hypotensives is associated with increases in total peripheral resistance. 8' 9 Changes in cardiac output have been variable.…”
mentioning
confidence: 99%
“…Each series of measurements included at least five determi- All patients also were treated chronically with orally administered ergotamine tartrate in doses of 2-6 mg/ day. They were followed initially for at least 10 [ during recumbency,'6 and patients should be monitored closely for this potential complication.…”
mentioning
confidence: 99%